08:56 AM EDT, 03/24/2026 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) slightly higher.

Amylyx Pharmaceuticals ( AMLX ) shares were up more than 4% after the company said it has completed patient enrollment for the phase 3 trial of avexitide in post-bariatric hypoglycemia.